Skip to main content
SpringerLink
Log in

Hyperbilirubinämie und Morbus haemolyticus neonatorum

  • Chapter
Neugeborenenintensivmedizin

  • 4450 Accesses

Zusammenfassung

Die Hyperbilirubinämie des Neugeborenen ist nach wie vor aktuell, zumal in den letzten Jahren auch in Ländern mit entwickeltem Gesundheitswesen der Kernikterus erneut aufgetreten ist. Kritische Grenzen der Bilirubinkonzentration bei Früh- und Reifgeborenen werden ebenso dargestellt wie das differenzialdiagnostische Vorgehen bei Hyperbilirbinämie. Besonderes Augenmerk wird auf den Morbus haemolyticus neonatorum gelegt. Die praktische Durchführung von Fototherapie und Blutaustauschtransfusion wird detailliert beschrieben.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Literatur

  1. Alcock GS, Liley H (2002) Immunoglobulin infusion for isoimmune haemolytic jaundice in neonates. Cochrane Database Syst Rev:CD003313

    Google Scholar 

  2. American Academy of Pediatrics (2004) Clinical practice guideline: Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics 114:297–316

    Google Scholar 

  3. Berns M, Ramsauer B, Goecke TW, Bührer C (2015) Hyperbilirubinämie des Neugeborenen – Diagnostik und Therapie. AWMF-Leitlinie 024–007

    Google Scholar 

  4. Bhutani VK, Johnson L (2006) Kernicterus in late preterm infants cared for as term healthy infants. Semin Perinatol 30:89–97

    Google Scholar 

  5. Bhutani VK, Johnson L, Sivieri EM (1999) Predictive ability of a predischarge hour-specific serum bilirubin for subsequent significant hyperbilirubinemia in healthy term and near-term newborns. Pediatrics 103:6–14

    Google Scholar 

  6. Bijl EJ, Bharwani KD, Houwen RH, de Man RA (2013) The long-term outcome of the Kasai operation in patients with biliary atresia: a systematic review. Neth J Med 71:170–3

    Google Scholar 

  7. Bratlid D, Nakstad B, Hansen TW (2011) National guidelines for treatment of jaundice in the newborn. Acta Paediatr 100:499–505

    Google Scholar 

  8. Ebbesen F, Andersson C, Verder H, Grytter C, Pedersen-Bjergaard L, Petersen JR, Schaarup J (2005) Extreme hyperbilirubinaemia in term and near-term infants in Denmark. Acta Paediatr 94:59–64

    Google Scholar 

  9. Gotink MJ, Benders MJ, Lavrijsen SW, Rodrigues Pereira R, Hulzebos CV, Dijk PH (2013) Severe neonatal hyperbilirubinemia in the Netherlands. Neonatology 104:137–42

    Google Scholar 

  10. Grimmer I, Berger-Jones K, Buhrer C, Brandl U, Obladen M (1999) Late neurological sequelae of non-hemolytic hyperbilirubinemia of healthy term neonates. Acta Paediatr 88:661–3

    Google Scholar 

  11. Hulzebos CV, Dijk PH, van Imhoff DE, Bos AF, Lopriore E, Offringa M, Ruiter SA, van Braeckel KN, Krabbe PF, Quik EH, van Toledo-Eppinga L, Nuytemans DH, van Wassenaer-Leemhuis AG, Benders MJ, Korbeeck-van Hof KK, van Lingen RA, Groot Jebbink LJ, Liem D, Mansvelt P, Buijs J, Govaert P, van Vliet I, Mulder TL, Wolfs C, Fetter WP, Laarman C; BARTrial Study Group (2014) The bilirubin albumin ratio in the management of hyperbilirubinemia in preterm infants to improve neurodevelopmental outcome: a randomized controlled trial--BARTrial. PLoS One 9:e99466

    Google Scholar 

  12. Inglis GD, Davies MW (2005) Prophylactic antibiotics to reduce morbidity and mortality in neonates with umbilical venous catheters. Cochrane Database Syst Rev:CD005251

    Google Scholar 

  13. Ip S, Chung M, Kulig J, O’Brien R, Sege R, Glicken S, Maisels MJ, Lau J (2004) An evidence-based review of important issues concerning neonatal hyperbilirubinemia. Pediatrics 114:e130–53

    Google Scholar 

  14. Johnson L, Bhutani VK, Karp K, Sivieri EM, Shapiro SM (2009) Clinical report from the pilot USA Kernicterus Registry (1992 to 2004). J Perinatol 29 (Suppl 1): S25–45

    Google Scholar 

  15. Kabra NS, Kumar M, Shah SS (2005) Multiple versus single lumen umbilical venous catheters for newborn infants. Cochrane Database Syst Rev:CD004498

    Google Scholar 

  16. Kumar P, Chawla D, Deorari A (2011) Light-emitting diode phototherapy for unconjugated hyperbilirubinaemia in neonates. Cochrane Database Syst Rev:CD007969

    Google Scholar 

  17. Kuzniewicz MW, Wickremasinghe AC, Wu YW, McCulloch CE, Walsh EM, Wi S, Newman TB (2014) Incidence, etiology, and outcomes of hazardous hyperbilirubinemia in newborns. Pediatrics 134:504–9

    Google Scholar 

  18. Maisels MJ, Watchko JF, Bhutani VK, Stevenson DK (2012) An approach to the management of hyperbilirubinemia in the preterm infant less than 35 weeks of gestation. J Perinatol 32:660–4

    Google Scholar 

  19. Maisels MJ, Watchko JF (2003) Treatment of jaundice in low birthweight infants. Arch Dis Child Fetal Neonatal Ed 88:F459–63

    Google Scholar 

  20. Mills JF, Tudehope D (2001) Fibreoptic phototherapy for neonatal jaundice. Cochrane Database Syst Rev:CD002060

    Google Scholar 

  21. Moise KJ Jr, Argoti PS (2012) Management and prevention of red cell alloimmunization in pregnancy: a systematic review. Obstet Gynecol 120:1132–9

    Google Scholar 

  22. Nagar G, Vandermeer B, Campbell S, Kumar M (2013) Reliability of transcutaneous bilirubin devices in preterm infants: a systematic review. Pediatrics 132: 871–81

    Google Scholar 

  23. Newman TB, Liljestrand P, Jeremy RJ, Ferriero DM, Wu YW, Hudes ES, Escobar GJ (2006) Outcomes among newborns with total serum bilirubin levels of 25 mg per deciliter or more. N Engl J Med 354:1889–900

    Google Scholar 

  24. Newman TB, Maisels MJ (2000) Less aggressive treatment of neonatal jaundice and reports of kernicterus: lessons about practice guidelines. Pediatrics 105: 242–5

    Google Scholar 

  25. Okwundu CI, Okoromah CAN, Shah PS (2012) Prophylactic phototherapy for preventing jaundice in preterm or low birth weight infants. Cochrane Database Syst Rev:CD007966

    Google Scholar 

  26. Sgro M, Campbell DM, Kandasamy S, Shah V (2012) Incidence of chronic bilirubin encephalopathy in Canada, 2007–2008. Pediatrics 130:e886–90

    Google Scholar 

  27. van Imhoff DE, Dijk PH, Hulzebos CV; BARTrial study group, Netherlands Neonatal Research Network (2011) Uniform treatment thresholds for hyperbilirubinemia in preterm infants: background and synopsis of a national guideline. Early Hum Dev 87:521–5

    Google Scholar 

  28. Wildhaber BE, McLin VA (2010) Schweizerisches Screeningprogramm für Gallengangatresie. Schweiz Med Forum 2010;10:480–2

    Google Scholar 

  29. Wong V, Chen WX, Wong KY (2006) Short- and long-term outcome of severe neonatal nonhemolytic hyperbilirubinemia. J Child Neurol 21:309–15

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Zentrum für Kinder- und Jugendmedizin, Universitätsklinikum Marburg, Baldingerstraße, 35043, Marburg

    Prof. Dr. Rolf F. Maier

Authors
  1. Prof. Dr. Rolf F. Maier
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer-Verlag GmbH Deutschland

About this chapter

Cite this chapter

Maier, R. (2017). Hyperbilirubinämie und Morbus haemolyticus neonatorum. In: Neugeborenenintensivmedizin. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-53576-9_13

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-53576-9_13

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-662-53575-2

  • Online ISBN: 978-3-662-53576-9

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Search

Navigation